Jaqueline Staeuble, CEO of Infotrace Medical was joined by Diane Tangun, Vesalio’s VP, Market Development in Switzerland FEB 11-13. Multiple Swiss stroke centers were visited to review clinical progress with NeVa. Technical discussions ensued with neuro-endovascular physicians regarding the Drop Zone Technique and their positive patient outcomes with NeVa. Vesalio is excited with the progress of our distributor partner …. a believer in our unique technology and investing to bring it to stroke patients in her home country.